American Resources: ReElement Technologies files eighth patent as it builds out lithium purification technology for brine extraction

ReElement Technologies (minority-held by American Resources Corp, NASDAQ:AREC) filed its eighth patent covering a chromatography-based process to produce ultra-high-purity lithium from brines, designed to follow direct lithium extraction (DLE) and convert concentrated streams into battery-grade material. The system is field-tested, handles multiple feedstocks (brine, hard rock, recycled batteries, coal waste), claims faster, smaller-footprint deployment with lower chemical inputs, and is positioned to domesticize refining capacity currently concentrated outside the U.S. and allied nations.

Analysis

Market structure: ReElement's chromatography IP (via AREC minority stake) targets a downstream chokepoint — battery-grade lithium purification — creating winners (ReElement/AREC, US DLE partners, domestic battery cathode/pack makers) and losers (concentrated overseas refiners and evaporation-pond operators). If commercialized at scale (12–36 months), expect domestic purification capacity to increase available battery-grade supply by a material amount (conservative estimate: 10–25% incremental throughput versus current US-refining baseline), exerting downward pressure on premium spreads for refined lithium.

Risk assessment: Key tail risks are scaling failure, patent challenge or slow permitting; assign a 15–30% probability to significant execution delay (>18 months) based on historical separations/IP commercialization timelines. Immediate market impact is likely muted (days), pilot data in 3–9 months will drive sentiment, and real capacity/pricing effects play out over 12–36 months. Hidden dependencies include access to consistent concentrated DLE feedstock, capital for deployment, and offtake contracts — any shortfall could nullify projected margin gains.

Trade implications: Short-term alpha will come from event-driven catalysts (pilot contracts, patent grants). Expect higher volatility in small-cap AREC on news; use capped option structures or small equity allocations. Broadly, successful US refining reduces long-term pricing power of dominant Asian refiners (ALB, SQM, Ganfeng analogues), creating relative-value shorts vs. US-focused processors and battery makers.

Contrarian view: The market underestimates scale/operational risk — chromatography at industrial brine scale can raise OPEX and chemical consumption, offsetting purity advantages. Historical parallels (rare-earth separations) show 24–60 month commercialization lags; therefore avoid extrapolating a quick supply shock. The unintended consequence: faster purification could depress lithium carbonate prices 15–30%, hurting upstream miners before downstream demand catches up.

Key Decisions for Investors

• Establish a tactical long of 2–3% NAV in American Resources Corp (NASDAQ:AREC) over 6–12 months, size to liquidity; target +50–100% if ReElement announces a commercial deployment or signed offtake within 6 months, set a hard stop-loss at -30% to limit binary-tech risk.
• Implement a pair trade: long AREC (2% NAV) / short Albemarle (NYSE:ALB) (0.8% NAV) over 12–24 months to capture domestic-onshoring of refining value; close/trim pair if ALB’s EBITDA margin expands >5 percentage points or if ReElement fails to show a paid pilot within 9 months.
• Buy a 9–12 month put spread on ALB sized to 0.5–1% NAV (e.g., 1x 10–15% OTM put spread) to hedge downside from a potential 15–30% drop in lithium prices driven by new purification capacity; unwind if lithium carbonate futures do not trade down >12% within 6 months or after public pilot success.
• Overweight (+2–4% relative) US/ally battery-material names with domestic refining plans (examples to research: Livent LTHM, Lithium Americas LAC) and rotate out of pure-play overseas refiners if ReElement secures a multi-party deployment within 12 months; reassess positions on each quarterly pilot update.